Invention Grant
- Patent Title: Bicyclic heterocycles as FGFR4 inhibitors
-
Application No.: US15712290Application Date: 2017-09-22
-
Publication No.: US10016438B2Publication Date: 2018-07-10
- Inventor: Liang Lu , Liangxing Wu , Bo Shen , Wenqing Yao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/444 ; A61K31/4375
Abstract:
The present disclosure relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
Public/Granted literature
- US20180008610A1 BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS Public/Granted day:2018-01-11
Information query
IPC分类:
